Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 25 of 47

24 April 2026 Inhalation ceutical Aerosols," Adv. Drug Del. Rev., 177 October 2021; https://doi.org/10.1016/j.addr.2021.113952. 12. Andersson, P. U., J. Clay, M. Parry, T. Iley, D. L. Roberts, L. Slator, et al., "Multi-Participant Blinded Investigation into Internal Losses of Medication in Commercially Available Mixing Inlets: Test- ing Different Orally Inhaled Product Classes Fol- lowing Pharmacopeial Methods," J. Aerosol Med. Pulm. Drug Deliv., Online, August 25, 2025; doi. org/10.1177/19412711251370473. 13. Baker, R. C., Flow Measurement Handbook, Cambridge University Press, Cambridge, UK (2000); Chapter 7. 14. Cantwell, B. J., Fundamentals of Compressible Flow, Department of Aeronautics and Astronautics, Stanford University, Stanford, CA, (January 2022); https://web.stanford.edu/~cantwell/AA210A_ C o u r s e _ Ma t e r i a l / A A 2 1 0 A _ C o u r s e _ B O O K / AA210_Fundamentals_of_Compressible_Flow_ BOOK_Brian_J_Cantwell_Jan_2022.pdf. 15. Roberts, D. L., "Acceptance Testing of Used Cas- cade Impactor Stages Based on Pressure Drop Mea- surements in a Flow System Managed with a Critical Flow Venturi: Part I—Laboratory Proof-of-Princi- ple," J. Aero. Med. Pulm. Drug Deliv., 37(1), 2-10 (2024); doi.org/10.1089/jamp.2023.0035. 16. Lee, J. F., F. W. Sears, ermodynamics, Addison- Wesley Publishing Company, Cambridge, MA (1955); https://ia601700.us.archive.org/11/items/ dli.ernet.449127/449127-ermodynamics.pdf. 17. Shapiro, A. H., e Dynamics and ermo- dynamics of Compressible Fluid Flow, Vol. I, John Wiley and Sons, New York, NY (1953). 18. Haas, J., C. Heil, M. D. Weir, omas' Calcu- lus, 14th edition, Pearson Education Inc., Boston, MA (2018). 19. ANSI/ISA-S75.02, "Control Valve Capacity Test Procedures," Instrument Society of America, Research Triangle Park, NC, (1996). 20. Carter, M. S., B. W. Sims, R. J. McKee, "Choking Pressure Ratio Guidelines for Critical Flow Venturis and the Study of Diffuser Pressure Distribution," Ninth International Symposium on Fluid Flow Mea- surement, Washington, DC, April 14-17, 2015. 21. Corke, T. C., Flow Control, Cambridge Univer- sity Press, Cambridge, UK (2024). Daryl L. Roberts, PhD, is President of Applied Particle Principles, LLC, 17347 Westham Estates Court, Hamil- ton, VA, 20158, US, Tel.: +1 612 845-3293, droberts@ particleprinciples.com, www.particleprinciples.com. copoeia 11.5, monograph 2.9.18. Preparations for Inhalation: Aerodynamic Assessment of Fine Parti- cles. EDQM, Strasbourg, France. 3. Japanese Ministry of Health, Labour, and Welfare, e Japanese Pharmacopoeia, 18th edition, June 2021; section 6.15 "Aerodynamic Particle Size Mea- surement for Inhalations," https://www.mhlw.go.jp/ content/11120000/000945683.pdf. 4. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), "Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Prod- ucts – Quality Considerations; Guidance for Indus- try," Silver Spring, MD; April 2018, Revision 1. 5. Newman, S. P., A. Hollingworth, A. R. Clark, "Effect of Different Modes of Inhalation on Drug Delivery from a Dry Powder Inhaler," Int. J. Pharm., 102, 127-132 (1994); https://doi. org/10.1016/0378-5173(94)90047-7. 6. Marple, V. A., D. L. Roberts, F. J. Romay, N. C. Miller, K. G. Truman, M. Van Oort, et al., "Next Generation Pharmaceutical Impactor -- Part I: Design," J. Aerosol Med., 16, 283-299 (2003); doi 10.1089/089426803769017659. 7. Mohammed, H., J. Arp, F. Chambers, M. Copley, V. Glaab, M. Hammond, et al., "Investigation of Dry Powder Inhaler (DPI) Resistance and Aerosol Disper- sion Timing on Emitted Aerosol Aerodynamic Par- ticle Sizing by Multistage Cascade Impactor When Sampled Volume is Reduced from Compendial Value of 4 L," AAPS PharmSciTech, 15(5), 1126- 1137 (2014); doi.org/10.1208/s12249-014-0111-1. 8. Mahler, D. A., "e Role of Inspiratory Flow in Selection and Use of Inhaled erapy for Patients with Chronic Obstructive Pulmonary Disease," Resp. Med., 161, January 2020; doi.org/10.1016/j. rmed.2019.105857. 9. Greguletz, R., P. U. Andersson, A. Cooper, F. Chambers, M. A. Copley, G. Daniels, et al., "A Cross-Industry Assessment of the Flow Rate-Time Profiles of Test Equipment Typically Used for Dry-Powder Inhaler (DPI) Testing: Part 1 – Com- pendial Apparatuses," Aerosol Sci. Tech., 54(12), 1424-1447 (2020). 10. Versteeg, H. K., D. L. Roberts, F. Chambers, A. Cooper, M. Copley, J. P. Mitchell, "A Cross-Industry Assessment of the Flow Rate-Elapsed Time Profiles of Test Equipment Typically Used for Dry-Powder Inhaler (DPI) Testing: Part 2 – Analysis of Tran- sient Air Flow in the Testing of DPIs with Compen- dial Cascade Impactors," Aerosol Sci. Tech., 54(12), 1448-1470 (2020). 11. Chow, M. Y. T., W. Tai, R. Y. K. Chang, H.-K. Chan, P. C. L. Kwok, "In Vitro-In Vivo Correlation of Cascade Impactor Data for Orally Inhaled Pharma-

Articles in this issue

Links on this page

view archives of Inhalation - INH0426